West Pharmaceutical Services, Inc. (WST)

Market Cap	15.28B
Revenue (ttm)	2.89B
Net Income (ttm)	492.70M
Shares Out	72.42M
EPS (ttm)	6.69
PE Ratio	31.54
Forward PE	34.82
Dividend	$0.84 (0.40%)
Ex-Dividend Date	Feb 7, 2025

Volume	2,071,027
Open	216.00
Previous Close	214.73
Day's Range	206.12 - 216.98
52-Week Range	197.01 - 400.88
Beta	1.00
Analysts	Strong Buy
Price Target	367.50 (+74.17%)
Earnings Date	Feb 13, 2025

About WST

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1923
• Employees: 10,600
• Stock Exchange: NYSE
• Ticker Symbol: WST
• Website: https://www.westpharma.com

Financial Performance

In 2024, WST's revenue was $2.89 billion, a decrease of -1.92% compared to the previous year's $2.95 billion. Earnings were $492.70 million, a decrease of -16.97%.

Analyst Forecast

According to 5 analysts, the average rating for WST stock is "Strong Buy." The 12-month stock price forecast is $367.5, which is an increase of 74.17% from the latest price.

Price Target

$367.5

(74.17% upside)

Analyst Consensus: Strong Buy